|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Fair value option | ||||||||||||||||||||
| Available for sale, at fair value (amortized cost: December 31, 2025 - $247) | ||||||||||||||||||||
| Equity securities, at fair value (cost: December 31, 2023 - $0; December 31, 2022 - $201) | ||||||||||||||||||||
| Mortgage loans, at fair value | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Other invested assets (includes $511 and $354 of assets measured at fair value at December 31, 2025 and 2024, respectively) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Reinsurance recoverables (includes $144 and $163 of recoverables measured at fair value as of December 31, 2025 and 2024, respectively) (includes $463 and $— of recoverables from affiliates as of December 31, 2025 and 2024, respectively) | ||||||||||||||||||||
| Receivables from parent and affiliates | ||||||||||||||||||||
| Net modified coinsurance receivable, at fair value | ||||||||||||||||||||
| Deposit asset, at fair value | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Other assets (Receivables from parent and affiliates: December 31, 2025 - $1; December 31, 2024 - $10) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total other assets (Receivables from parent and affiliates: December 31, 2025 - $1; December 31, 2024 - $10) | ||||||||||||||||||||
| Separate account assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Insurance liabilities | ||||||||||||||||||||
| Policyholder contract deposits | ||||||||||||||||||||
| Funds withheld payable to affiliates | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Payables to parent and affiliates | ||||||||||||||||||||
| Net modified coinsurance payable, at fair value | ||||||||||||||||||||
| Liabilities associated with secured borrowing arrangements | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total other liabilities | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock, $100 par value; 25,000 shares authorized, issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...
